Review Article
Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye Diseases
Table 7
Inhibitor of HSV-1 reactivation in latently infected rabbits.
| HSV-1 Strain | Inhibitor | Frequency of detection of reactivation with inhibitor | Frequency of detection of reactivation without inhibitor | Authors, year (reference no.) |
| McKrae | Propranolol with epinephrine iontophoresis | 56/84 (67%) with 20 mg/kg; 23/42 (55%) with 200 mg/kb | 46/84 (55%) and 20/42 (48%) | Garza and Hill, 1997 [82] | McKrae | Propranolol with Cx and Dx | 27/56 (48%) | 29/63 (46%) | Garza and Hill, 1997 [82] | 17 Syn+ | Propranolol with epinephrine iontophoresis | 43/70 (61%) with 5 mg/kg;29/56 (52%) with 200 mg/kg | 34/70 (49%) and 7/8 (88%) | Garza and Hill, 1997 [82] | 17 Syn+ | Propranolol with Cx and Dx | 24/63 (38%) | 21/56 (38%) | Garza and Hill, 1997 [82] | McKrae | Propranolol | 20/264 (7.6%) | 28/216 (13%) | Kaufman et al., 1996 [80] | 17 Syn+ | Propranolol | 11/336 (3.3%) | 31/264 (11.7%) | Kaufman et al., 1996 [80] | McKrae | Bupropion | 9/20 (45%) | 13/29 (65%) | Myles et al., 2004 [89] | McKrae | Bupropion with nicotine transdermal | 13/36 (36.1%) | 35/36 (97.2%) | Myles et al., 2004 [89] | W strain | Alpha blockers | 10/14 (71%) | 13/14 (93%) | Gordon et al., 1990 [90] |
|
|
Cx: cyclophosphamide and Dx: dexamethasone.
|